Opzioni
Antibacterial rifampicin-loaded electrospun polycaprolactone membranes for ureteral regeneration
2022
Periodico
EUROPEAN UROLOGY OPEN SCIENCE
Abstract
Author of the study: Nowadays partial or complete ureteral loss
following resection or injuries of various etiology is managed with
different surgical techniques involving local tissue flaps or autologous
tissues interposition. In the last years ureteral tissue engineering using
membranes, tubular scaffolds or decellularized matrices has shown
promising results for ureteral substitution. The aim of this study is to
evaluate the use of antibacterial electrospun polycaprolactone/
rifampicin (PCL/RIF) membranes for the production of ureteral
scaffolds with antibacterial properties.
Materials and methods: Electrospinning processwas used to produce
the membranes that were subsequently impregnated with rifampicin.
Membranes stability was evaluated by immersion in Simulated Body
Fluid (SBF) at 37 °C. Mechanical properties were evaluated by uniaxial
tensile tests, Young’s modulus was calculated for each sample. UV
spectrophotometry was used to evaluate in vitro release of rifampicin.
The ability of PCL/Rif membranes to sustain cell adhesion and
proliferation was evaluated by seeding human urothelial bladder
carcinoma cells on the membranes. In order to investigate the
antibacterial effect of PCL/Rif membranes, in vitro antibacterial tests
were performed using bacterial strains belonging to the “ESKAPE”
group.
Results: PCL/Rif membranes are characterized by a random distribution
of fibers with an average diameter of 0.52 μm.Water contact angle
for PCL and PCL/Rif membranes is around 125° and decreases to 0°
after air-plasma treatment. When culture medium is used as testing
fluid PCL and PCL/Rif contact angles are 116° and 12° respectively.
Membranes are deformable up to 300% of their initial dimension and
possess an elastic Young modulus of about 20 kPa; after 3 weeks
membranes gain the property to sustain a 100% deformation before
rupture. The 72% of rifampicin load is released by the membranes in
the first 24 hours. Proliferation assay showed a seven-fold increase of
cell number adhered on the membranes after 7 days of culture. At the
same time in presence of PCL/Rif membranes, rates of bacterial
proliferation inhibition ranged from 75 to 94% compared to controls.
Conclusions: PCL/Rif membranes represent a promising starting point
in the production of ureteral scaffolds with antibacterial properties for
ureteral substitution.
Diritti
open access
license:creative commons
license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/